Modified Glasgow Prognostic Score as a Predictor of Prognosis in mRCC Treated With Nivolumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Genitourinary Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab
Clin Genitourin Cancer 2020 Nov 10;[EPub Ahead of Print], R Fujiwara, K Takemura, M Fujiwara, T Yuasa, S Yasuoka, Y Komai, N Numao, S Yamamoto, J YoneseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.